NASDAQ:ADMS
Delisted
Adamas Pharmaceuticals Stock News
$8.22
+0 (+0%)
At Close: May 27, 2022
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
Stocks That Hit 52-Week Lows On Wednesday
03:41pm, Wednesday, 11'th Mar 2020
During Wednesday's morning session, 690 stocks hit new 52-week lows.
Intriguing Points:
Boeing (NYSE: BA) was the biggest company on a market cap basis to set a new...
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu
Edited Transcript of ADMS earnings conference call or presentation 25-Feb-20 9:30pm GMT
06:26pm, Tuesday, 10'th Mar 2020
Q4 2019 Adamas Pharmaceuticals Inc Earnings Call
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Bi
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
Earnings Update: Here's Why Analysts Just Lifted Their Adamas Pharmaceuticals, Inc. Price Target To US$12.69
11:26am, Friday, 28'th Feb 2020
There's been a major selloff in Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) shares in the week since it released its...
Adamas Reports Fourth Quarter and Full Year 2019 Financial Results
09:03pm, Tuesday, 25'th Feb 2020
- Full year 2019 GOCOVRI® product sales of $54.6 million, a 60% increase over 2018;total paid prescriptions grew approximately 66% to 25,780 - Fourth quarter 2019 GOCOVRI®.
The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
01:28pm, Tuesday, 25'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainst
Adamas Pharmaceuticals Q4 EPS $(0.83) Beats $(0.85) Estimate, Sales $16.348M Beat $15.81M Estimate
12:00am, Tuesday, 25'th Feb 2020Cronos (CRON) to Report Q4 Earnings: What's in the Cards?
02:02pm, Monday, 24'th Feb 2020
Investors will focus on Cronos' (CRON) regular top- and bottom-line numbers, along with its pipeline progress, when it reports Q4 results.
Cronos (CRON) to Report Q4 Earnings: What's in the Cards?
02:02pm, Monday, 24'th Feb 2020
Investors will focus on Cronos' (CRON) regular top- and bottom-line numbers, along with its pipeline progress, when it reports Q4 results.